Trials / Unknown
UnknownNCT05740423
Standardization of Anti-Seizure Medications Withdrawals After Seizure Remission in Young Patients With Epilepsy
Anti-Seizure Medications Withdrawals After 2 Years of Seizure Remission
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (estimated)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The proper period of anti-seizure medication (ASM) treamtment is important for decreasing side effect of ASM and recurrence of seizure. We evaluate reliable risk factor analysis for safe withdrawal of ASM in children with epilepsy. Futhermore, we develop the scoring system for prediction of seizure recurrence to set the standard for safe withdrawal of ASM.
Detailed description
The proper period of anti-seizure medication (ASM) treamtment is important for decreasing side effect of ASM and recurrence of seizure. We evaluate reliable risk factor analysis for safe withdrawal of ASM in children with epilepsy. Futhermore, we develop the scoring system for prediction of seizure recurrence to set the standard for safe withdrawal of ASM. The enroll criteria as follow: 1. patients with epilepsy or acute provoked seizure accroding to the ILAE definition 2. patients who have been 2 years of seizure free with or without ASM The patients with seizure recurrence during follow-up or end of follow-up period of 24 months will end this stutdy.
Conditions
Timeline
- Start date
- 2021-08-30
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2023-02-23
- Last updated
- 2023-02-23
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05740423. Inclusion in this directory is not an endorsement.